Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 4 March 2003
Vol. 2003, Issue 172, p. re4
[DOI: 10.1126/stke.2003.172.re4]


Physiologic and Pathologic Events Mediated by Intramembranous and Juxtamembranous Proteolysis

Todd E. Golde* and Christopher B. Eckman

Mayo Clinic Jacksonville, Department of Neuroscience, 4500 San Pablo Road, Jacksonville, FL 32224, USA.

Gloss: This STKE review describes one of the more recently recognized ways in which cells transmit signals across lipid bilayers--through the action of proteases on proteins that span the membrane. In some cases, a protease cleaves a signaling protein within its membrane-spanning domain to release either the target protein's cytoplasmic domain or its extracellular domain. Once cleaved and released from the membrane, these soluble domains can transmit a signal either locally or at some distance from the site of cleavage. This type of proteolytic cleavage is referred to as intramembranous proteolysis (IP). In a second type of proteolytic cleavage of transmembrane proteins that mediates cell signaling, the target protein is cleaved at a site close to, but not within, the transmembrane domain. This type of proteolysis is called juxtamembranous proteolysis (JP). JP and IP can sequentially mediate signaling events, with the combined action of these two cleavages resulting in transmission of signals within the cell. Several important cellular signaling pathways are regulated by both JP and IP, for example, regulation of the transcription of enzymes that control cholesterol synthesis; developmental regulation of cell differentiation; and growth regulation in somatic cells. IP and JP also have important roles in certain diseases, such as Alzheimer's disease. Because some of the proteases mediating IP and JP can be targeted by small drug-like molecules, inhibitors targeting these proteases are likely to alter both physiologic and pathologic events triggered by IP and JP.

*Corresponding author: Telephone, 904-953-2538; fax, 904-953-7370; e-mail, tgolde{at}

Citation: T. E. Golde, C. B. Eckman, Physiologic and Pathologic Events Mediated by Intramembranous and Juxtamembranous Proteolysis. Sci. STKE 2003, re4 (2003).

Proteases and Signaling.
S. Wilk (2005)
Sci. STKE 2005, tr15
   Abstract »    Full Text »    PDF »
Does the Road to Muscle Rejuvenation Go Through Notch?.
J. B. Miller and C. P. Emerson Jr. (2003)
Sci. Aging Knowl. Environ. 2003, pe34-34
   Abstract »    Full Text »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882